SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028021
Filing Date
2018-11-07
Accepted
2018-11-07 16:11:42
Documents
69
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q svra-10q_20180930.htm 10-Q 2024212
2 EX-31.1 svra-ex311_11.htm EX-31.1 13952
3 EX-31.2 svra-ex312_9.htm EX-31.2 13967
4 EX-32.1 svra-ex321_6.htm EX-32.1 10706
  Complete submission text file 0001564590-18-028021.txt   7719258

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT svra-20180930.xml EX-101.INS 1668690
6 XBRL TAXONOMY EXTENSION SCHEMA svra-20180930.xsd EX-101.SCH 65983
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE svra-20180930_cal.xml EX-101.CAL 60318
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE svra-20180930_def.xml EX-101.DEF 222813
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20180930_lab.xml EX-101.LAB 467896
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20180930_pre.xml EX-101.PRE 352297
Mailing Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746
Business Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746 512-614-1848
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 181166452
SIC: 2834 Pharmaceutical Preparations